Mixed mode chromatography in biosimilars development - Overview
Market for therapeutic proteins such as monoclonal antibodies (mAbs), growth hormones, other
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Market for therapeutic proteins such as monoclonal antibodies (mAbs), growth hormones, other
In view of the global changes in disease pattern, reduced health budget
Successful development of biosimilars is dependent upon the establishment of validated and
Sepsis remains a leading cause of death in hospitalized patients, despite the
Twenty-four countries have already approved biosimilars. Some of them, like China
By 2020, patents will have expired for originator biologics accounting for about
The market for biosimilars is evolving, rapidly. Based on the growing confidence
According to recent FDA guidance, a Biosimilar is a biological product which
While, the development of Biologics is complicated and a strategy driven approach
The demonstration of biosimilarity is critical to the approval of biosimilar products
Mammalian cell cultures are complex processes where cells are cultivated under highly
A biosimilar product is a biological product that is approved based on
Biopharmaceuticals are biological medical products derived from cell culture or fermentation to
The cell line development group at NeuClone generates high quality cell lines
The development pathway of a biosimilar is unlike that of a novel
The EU operates a well-established biosimilars review process that has more
The passage of 2009 Biologics Price Competition and Innovation Act of 2009
The US Biosimilars landscape is developing in parallel with that of Europe
In addition to development, manufacturing and commercial challenges, patent legal issues have
The past year has seen a great deal of activity related to
Research and Development nessecitates important financial investments, in particular in the pharmaceutical
The National Health Service (NHS) is a single healthcare system providing care
The regulatory landscape for the development of biosimilars in the US and
Pawan Saharan invented Radha108 Nano Peptides extracted from Bovine colostrum that naturally
Adoption of biosimilars is increasingly attractive to payers around the globe due
For authors and organisers
Find the right journal for your paper and submit your manuscript.